Med. praxi. 2016;13(1):34-38 | DOI: 10.36290/med.2016.007

Colorectal carcinoma - present view on diagnostics and treatment

MUDr.Petr Diviš, Ph.D.1, MUDr.Kristýna Divišová2, MUDr.Jana Katolická, Ph.D.3, MUDr.Simona Rotnáglová3
1 SurGal Clinic, Brno
2 Onkologie, Kroměřížská nemocnice a.s.
3 Onkologicko-chirurgické oddělení, Fakultní nemocnice u sv. Anny v Brně

A colorectal carcinoma (CRC) is considered to be the most frequent GIT malignancy and is the second most frequent amongst

all malignant tumors. There is only a breast cancer in woman and a prostate cancer in men more plentiful. There are 8000 newly

diagnosed cases of CRC every year. And 4000 patients dies of CRC yearly. There are plentiful exogenic and endogenic risk factors

rising probability of appearance of CRC. A CRC diagnostics and treatment is a multidisciplinary task. Close co-operation of experts

in many fields is the only way to early diagnostics and proper treatment of CRC. Surgery is considered to be fundamental in strategy

of oncological treatment of CRC. Implementation of „indication boards“ and onco-surgical specialization plays important role in

improving CRC management. The difference in number of early stages diagnosed in other developed countries and advanced stages

diagnosed in the Czech Republic is found the most alarming. Introduction of a screening programs should bring a turning point

in this infamous trend. It is obvious that treatment of early stages of CRC is simpler economical and could lead to total recovery.

Keywords: colorectal cancer, multidisciplinary care, screening programs, oncosurgery

Published: March 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Diviš P, Divišová K, Katolická J, Rotnáglová S. Colorectal carcinoma - present view on diagnostics and treatment. Med. praxi. 2016;13(1):34-38. doi: 10.36290/med.2016.007.
Download citation

References

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 (online). International Agency for Research on Cancer, Lyon (France) 2013. Dostupný z WWW: http://globocan.iarc.fr.
  2. Ústav zdravotnických informací a statistiky ČR: Národní onkologický registr (NOR) (13. 12. 2013). http://www.uzis.cz/registry-nzis/nor.
  3. Bauer J. Vznik nádoru. Onkologie praktického lékaře. Praha: Snímal, 1994: 8-19.
  4. Chan A, Giovannuci E. Primary prevention of colorectal cancer. Gastroenterology 2010; 138(6): 2029-2043. Go to original source... Go to PubMed...
  5. Eliaikim R, Yassin K, Adler S, et al. Prospective multicer performance evaluation of the second-generation colon capsule compared with colonoscopy. Ebdoscopy 2009; 41(12): 1026-1031. Go to original source... Go to PubMed...
  6. Seef LC, Nadel MR, Klabunde CN, et al. Patterns et predictors of colorectal cancor test use in the adult U.S. population. Cancor 2004, 100: 2093-2103. Go to original source... Go to PubMed...
  7. Adam Z, Vorlíček J, Vaníček J, et al. Diagnostické a léčebné postupy maligních chorob. 2., přepracované a doplněné vydání. Praha 2004. Grada.
  8. TNM klasifikace zhoubných nádorů, 7. vydání 2009, česká verze 2011: 91-92.
  9. Diviš P, Vlček P, Čapov I, Divišová K, Katolická J, Vaníček J, Kotulánová E. Hodnocení neoadjuvantní chemoradioterapie u lokálně pokročilého karcinomu rekta srovnáním objemu tumoru před léčbou a po léčbě. Klin Onkol 2010.
  10. Modrá kniha, Doporučené postupy.
  11. Farmakoterapie, Monografie kolorektální karcinom 2013.
  12. Zavoral M, Suchánek S, Závada F, et al. Colorectal cancer screening in Europe. World J Gastroenterol, 2009; 15: p. 5907-5915. Go to original source... Go to PubMed...
  13. Seifert B, Král N. Screening kolorektálního karcinomu v roce 2009. Practicus, 2009; 3: 42-45.
  14. Král N, Seifert B. Změny ve screeningu kolorektálního karcinomu - krok správným směrem? Onkologie, 2010; 4: 251-255.
  15. Májek O, Daneš J, Zavoral M, et al. Czech National Cancer Screening Programmes in 2010. Klin Onkol, 2010; 23: 343-353. Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.